Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 842 across all filing types
Latest filing 2024-05-12 Regulatory Filings
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Shares Out of Escrow 2 pages 673.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 13 May 2024 from Bioxyne Limited regarding the release of 1,230,000,000 ordinary shares from escrow on 19 May 2024. It also mentions that major shareholders holding 1,000,000,000 shares have agreed to a further voluntary escrow extension. The content is an announcement about share escrow status and shareholder commitments, with no financial statements, earnings data, or detailed report content. The document length is 4231 characters, which is relatively short and primarily serves as a regulatory announcement about share escrow and shareholder commitments. This fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like Share Issue/Capital Change or Major Shareholding Notification, since it concerns escrow release and voluntary escrow extension rather than new share issuance or ownership threshold crossing.
2024-05-12 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 986.9KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 30 April 2024 reporting on the quarter ended 31 March 2024. It includes detailed financial and operational information such as revenue figures, cash flow statements, manufacturing licenses, capital raises, and cash balances. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed entities, confirms this is a quarterly financial report. The document contains substantive financial data and analysis for the quarter, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-29 English
Application for quotation of securities - BXN 6 pages 18.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from BIOXYNE LIMITED regarding the application for quotation of newly issued securities on the ASX. It details the number of securities to be quoted, issue dates, and related information about the securities placement. This type of document is a formal application to list or quote securities on the stock exchange, which corresponds to a capital or financing update rather than a financial report or other categories. The document is not a financial report, earnings release, or regulatory filing in the sense of compliance or certification. It is specifically an announcement related to capital structure changes and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content fully support this classification with high confidence.
2024-04-21 English
Cleansing Notice 2 pages 703.7KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Notice pursuant to Section 708A(5)(e) of the Corporations Act 2001, related to the issue of shares in a capital raise. It references compliance with disclosure obligations and provides details about the share issuance. There are no financial statements, detailed financial analysis, or report content. The document is an announcement about a capital raising event and compliance notice rather than a full financial report or detailed capital structure update. Given the nature of the content focusing on share issuance and compliance notice related to capital raising, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4592 characters, which is consistent with an announcement rather than a full report.
2024-04-21 English
Bioxyne Receives Firm Commitments to Raise $1.45 Million 2 pages 731.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 18 April 2024 from Bioxyne Limited regarding the receipt of firm commitments to raise $1.45 million through issuing new shares. It details the purpose of the capital raise, the number of shares to be issued, the price, and the use of funds. There are no financial statements, detailed financial performance data, or comprehensive analysis typical of an Annual Report or Interim Report. The content focuses on a financing activity, specifically a capital raise through share issuance. Therefore, this document fits the category of a Capital/Financing Update (CAP). The document length is 5286 characters, which is sufficient to contain substantive information about the financing event rather than just a brief announcement or a report publication notice.
2024-04-17 English
Proposed issue of securities - BXN 5 pages 17.6KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX announcement for a proposed issue of securities. It details the number of securities to be issued, the issue price, the class of securities, and compliance with ASX Listing Rules. The document is focused on the announcement of a placement or other type of securities issue, including timetable and conditions. There are no financial statements or detailed financial analysis present, only the announcement of the capital raising event. This fits the definition of a Capital/Financing Update (CAP) filing type, which covers updates on company fundraising and capital structure changes.
2024-04-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.